Wnt/β-catenin signaling is critical for various cellular processes in multiple cell types,including osteoblast(OB)differentiation and function.Exactly how Wnt/β-catenin signaling is regulated in OBs remain elusive.A...Wnt/β-catenin signaling is critical for various cellular processes in multiple cell types,including osteoblast(OB)differentiation and function.Exactly how Wnt/β-catenin signaling is regulated in OBs remain elusive.ATP6AP2,an accessory subunit of V-ATPase,plays important roles in multiple cell types/organs and multiple signaling pathways.However,little is known whether and how ATP6AP2 in OBs regulates Wnt/β-catenin signaling and bone formation.Here we provide evidence for ATP6AP2 in the OB-lineage cells to promote OB-mediated bone formation and bone homeostasis selectively in the trabecular bone regions.Conditionally knocking out(CKO)ATP6AP2 in the OB-lineage cells(Atp6ap2^(Ocn-Cre))reduced trabecular,but not cortical,bone formation and bone mass.Proteomic and cellular biochemical studies revealed that LRP6 and N-cadherin were reduced in ATP6AP2-KO BMSCs and OBs,but not osteocytes.Additional in vitro and in vivo studies revealed impairedβ-catenin signaling in ATP6AP2-KO BMSCs and OBs,but not osteocytes,under both basal and Wnt stimulated conditions,although LRP5 was decreased in ATP6AP2-KO osteocytes,but not BMSCs.Further cell biological studies uncovered that osteoblastic ATP6AP2 is not required for Wnt3a suppression ofβ-catenin phosphorylation,but necessary for LRP6/β-catenin and N-cadherin/β-catenin protein complex distribution at the cell membrane,thus preventing their degradation.Expression of activeβ-catenin diminished the OB differentiation deficit in ATP6AP2-KO BMSCs.Taken together,these results support the view for ATP6AP2 as a critical regulator of both LRP6 and N-cadherin protein trafficking and stability,and thus regulatingβ-catenin levels,demonstrating an un-recognized function of osteoblastic ATP6AP2 in promoting Wnt/LRP6/β-catenin signaling and trabecular bone formation.展开更多
Due to the limitations of conventional chemotherapy including side effects,poor prognosis,and drug resistance,there is an urgent need for the development of a novel multi-functional combined therapy strategy.Dopamine-...Due to the limitations of conventional chemotherapy including side effects,poor prognosis,and drug resistance,there is an urgent need for the development of a novel multi-functional combined therapy strategy.Dopamine-modified oxaliplatin prodrug(OXA-DA)was successfully synthesized in this study to ameliorate the organ distribution of oxaliplatin for improving the drug efficacy and reducing toxic side effects,and OXA-DA was applied to develop a porous oxaliplatin cross-linked polydopamine nanoparticle for loading siPD-L1 to construct multifunctional nanoplatform.The multifunctional nanoplatform was modified with poly(2-ethyl-2-oxazoline)(PEOz),which occurred charge reversal in the tumor microenvironment,and exerted the lysosomal escape effect in tumor cells to improve the bioavailability of small interfering RNA targeting programmed cell death-ligand 1(siPD-L1).The pH-responsive charge reversal,photothermal,biodegradation,lysosomal escape ability,PD-L1 protein degradation,toxicity properties and multiple antitumor effects were comprehensively evaluated in vitro and in vivo experiments.The findings indicated that OXA-DA-siPD-L1@PDA-PEOz excellently induced tumor cell necrosis and apoptosis as a result of the synergistic effect of chemo-photothermal therapy,and upregulated CD8+T cells produced interferon-γ(IFN-γ)to further attack the tumor cells.In conclusion,the novel nanoplatform-mediated chemo/photothermal/immunotherapy has promising clinical applications in the treatment of malignant tumors.展开更多
In this study,a comprehensive analysis of microstructural features,morphology,crystal structures,and interface structures of long-period stacking ordered(LPSO)structures in a non-equilibrium Mg_(97)Zn_(1)Y_(16)Ca_(0.4...In this study,a comprehensive analysis of microstructural features,morphology,crystal structures,and interface structures of long-period stacking ordered(LPSO)structures in a non-equilibrium Mg_(97)Zn_(1)Y_(16)Ca_(0.4)alloy cast in a steel mold was carried out.The addition of Ca element plays an important role in the refinement of LPSO structure.The result reveals new poly-types including 20H F2F2F4,60R(F2F3F3)_(3),and 66H F2F3F3F2(F6)_(4)featuring a 6-Mg structure,alongside the prevalent 18R and 14H LPSO structures.The incoherent interface between 20H and the Mg matrix is split into two dislocation arrays,leading to the formation of a segment of 60R_(1).Moreover,the superstructure 116L,designated as(F2)_(18)F4,is formed through the ordered distribution of F4 stacking faults in 18R.展开更多
Neuronal mitochondrial damage is the primary characteristic of Alzheimer's disease(AD);as mitochondrial micro RNAs(mi RNAs)are crucial for maintaining mitochondrial function,developing a detection system for mitoc...Neuronal mitochondrial damage is the primary characteristic of Alzheimer's disease(AD);as mitochondrial micro RNAs(mi RNAs)are crucial for maintaining mitochondrial function,developing a detection system for mitochondrial mi RNAs and applying it for AD treatment is of great significance.Herein,we report CeO2-DNA-RNA hybrid chain(DRP)/mitochondrial aptamers(MA)nanoclusters,formed using specially modified 5 nm sized cerium dioxide(CeO_(2))nanoparticles,to achieve AD diagnosis and treatment by targeting mitochondrial mi RNA-204.First,nanomaterials with unique reactive oxygen species-scavenging functions could easily enter the central nervous system,and surface modification with mitochondrial aptamers facilitated successful mitochondrial targeting.Furthermore,surface modification of nanomaterials with DNA-RNA hybrid biological detection probes was used to detect mi RNA-204 in AD and simultaneously perform gene-silencing therapy.In 3×Tg-AD model mice,CeO_(2)-DRP/MA aggregated into neuronal mitochondria,silenced mitochondrial mi RNA-204,and restored the damaged mitochondria for AD treatment.The promising diagnostic and therapeutic functions of CeO_(2)-DRP/MA demonstrate its better performance as a diagnostic and therapeutic system targeting mitochondrial mi RNA.展开更多
基金supported in part by grants from the National Institutes of Health(AG045781,AG051510,and AG066526)(to WCX).
文摘Wnt/β-catenin signaling is critical for various cellular processes in multiple cell types,including osteoblast(OB)differentiation and function.Exactly how Wnt/β-catenin signaling is regulated in OBs remain elusive.ATP6AP2,an accessory subunit of V-ATPase,plays important roles in multiple cell types/organs and multiple signaling pathways.However,little is known whether and how ATP6AP2 in OBs regulates Wnt/β-catenin signaling and bone formation.Here we provide evidence for ATP6AP2 in the OB-lineage cells to promote OB-mediated bone formation and bone homeostasis selectively in the trabecular bone regions.Conditionally knocking out(CKO)ATP6AP2 in the OB-lineage cells(Atp6ap2^(Ocn-Cre))reduced trabecular,but not cortical,bone formation and bone mass.Proteomic and cellular biochemical studies revealed that LRP6 and N-cadherin were reduced in ATP6AP2-KO BMSCs and OBs,but not osteocytes.Additional in vitro and in vivo studies revealed impairedβ-catenin signaling in ATP6AP2-KO BMSCs and OBs,but not osteocytes,under both basal and Wnt stimulated conditions,although LRP5 was decreased in ATP6AP2-KO osteocytes,but not BMSCs.Further cell biological studies uncovered that osteoblastic ATP6AP2 is not required for Wnt3a suppression ofβ-catenin phosphorylation,but necessary for LRP6/β-catenin and N-cadherin/β-catenin protein complex distribution at the cell membrane,thus preventing their degradation.Expression of activeβ-catenin diminished the OB differentiation deficit in ATP6AP2-KO BMSCs.Taken together,these results support the view for ATP6AP2 as a critical regulator of both LRP6 and N-cadherin protein trafficking and stability,and thus regulatingβ-catenin levels,demonstrating an un-recognized function of osteoblastic ATP6AP2 in promoting Wnt/LRP6/β-catenin signaling and trabecular bone formation.
基金the National Natural Science Foundation of China(Nos.32071342 and 32101065)the Natural Science Foundation of Guangdong Province(Nos.2023A1515012015,2022A1515110271 and 2020A1515011353).
文摘Due to the limitations of conventional chemotherapy including side effects,poor prognosis,and drug resistance,there is an urgent need for the development of a novel multi-functional combined therapy strategy.Dopamine-modified oxaliplatin prodrug(OXA-DA)was successfully synthesized in this study to ameliorate the organ distribution of oxaliplatin for improving the drug efficacy and reducing toxic side effects,and OXA-DA was applied to develop a porous oxaliplatin cross-linked polydopamine nanoparticle for loading siPD-L1 to construct multifunctional nanoplatform.The multifunctional nanoplatform was modified with poly(2-ethyl-2-oxazoline)(PEOz),which occurred charge reversal in the tumor microenvironment,and exerted the lysosomal escape effect in tumor cells to improve the bioavailability of small interfering RNA targeting programmed cell death-ligand 1(siPD-L1).The pH-responsive charge reversal,photothermal,biodegradation,lysosomal escape ability,PD-L1 protein degradation,toxicity properties and multiple antitumor effects were comprehensively evaluated in vitro and in vivo experiments.The findings indicated that OXA-DA-siPD-L1@PDA-PEOz excellently induced tumor cell necrosis and apoptosis as a result of the synergistic effect of chemo-photothermal therapy,and upregulated CD8+T cells produced interferon-γ(IFN-γ)to further attack the tumor cells.In conclusion,the novel nanoplatform-mediated chemo/photothermal/immunotherapy has promising clinical applications in the treatment of malignant tumors.
基金supported by the open research fund of Songshan Lake Materials Laboratory(No.2022SLABFN08)Guangxi Science and Technology Base and Talents Special Project(Nos.Guike AD20297034 and AD21220053)+2 种基金the National Natural Science Foundation of China(No.51801214 and 52171021)the Research Start-up Funding from Guangxi University of Science and Technology(No.03200150)the Middle-aged and Young Teachers’Basic Ability Promotion Project of Guangxi(No.2022KY0329)。
文摘In this study,a comprehensive analysis of microstructural features,morphology,crystal structures,and interface structures of long-period stacking ordered(LPSO)structures in a non-equilibrium Mg_(97)Zn_(1)Y_(16)Ca_(0.4)alloy cast in a steel mold was carried out.The addition of Ca element plays an important role in the refinement of LPSO structure.The result reveals new poly-types including 20H F2F2F4,60R(F2F3F3)_(3),and 66H F2F3F3F2(F6)_(4)featuring a 6-Mg structure,alongside the prevalent 18R and 14H LPSO structures.The incoherent interface between 20H and the Mg matrix is split into two dislocation arrays,leading to the formation of a segment of 60R_(1).Moreover,the superstructure 116L,designated as(F2)_(18)F4,is formed through the ordered distribution of F4 stacking faults in 18R.
基金supported by National Key Research and Development Program of China(No.2023YFD1800105)Long-gang District Medical and Health Technology Research Project(No.LGKCYLWS2022024)+2 种基金the Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences(No.2023-JKCS-12)Science and Technology Research Project of Colleges and Universities in Hebei Province(No.ZD2020306)the Medical Health Technology Innovation Project of Chinese Academy of Medical Sciences(No.2021-I2M-1-058)。
文摘Neuronal mitochondrial damage is the primary characteristic of Alzheimer's disease(AD);as mitochondrial micro RNAs(mi RNAs)are crucial for maintaining mitochondrial function,developing a detection system for mitochondrial mi RNAs and applying it for AD treatment is of great significance.Herein,we report CeO2-DNA-RNA hybrid chain(DRP)/mitochondrial aptamers(MA)nanoclusters,formed using specially modified 5 nm sized cerium dioxide(CeO_(2))nanoparticles,to achieve AD diagnosis and treatment by targeting mitochondrial mi RNA-204.First,nanomaterials with unique reactive oxygen species-scavenging functions could easily enter the central nervous system,and surface modification with mitochondrial aptamers facilitated successful mitochondrial targeting.Furthermore,surface modification of nanomaterials with DNA-RNA hybrid biological detection probes was used to detect mi RNA-204 in AD and simultaneously perform gene-silencing therapy.In 3×Tg-AD model mice,CeO_(2)-DRP/MA aggregated into neuronal mitochondria,silenced mitochondrial mi RNA-204,and restored the damaged mitochondria for AD treatment.The promising diagnostic and therapeutic functions of CeO_(2)-DRP/MA demonstrate its better performance as a diagnostic and therapeutic system targeting mitochondrial mi RNA.
